562 related articles for article (PubMed ID: 28993218)
1. Novel therapeutic targets in diabetic macular edema: Beyond VEGF.
Urias EA; Urias GA; Monickaraj F; McGuire P; Das A
Vision Res; 2017 Oct; 139():221-227. PubMed ID: 28993218
[TBL] [Abstract][Full Text] [Related]
2. Novel pharmacotherapies in diabetic retinopathy: Current status and what's in the horizon?
Das A; McGuire PG; Monickaraj F
Indian J Ophthalmol; 2016 Jan; 64(1):4-13. PubMed ID: 26953018
[TBL] [Abstract][Full Text] [Related]
3. Diabetic Macular Edema: Pathophysiology and Novel Therapeutic Targets.
Das A; McGuire PG; Rangasamy S
Ophthalmology; 2015 Jul; 122(7):1375-94. PubMed ID: 25935789
[TBL] [Abstract][Full Text] [Related]
4. Diabetic macular edema.
Lang GE
Ophthalmologica; 2012; 227 Suppl 1():21-9. PubMed ID: 22517122
[TBL] [Abstract][Full Text] [Related]
5. Current intravitreal pharmacologic therapies for diabetic macular edema.
Colucciello M
Postgrad Med; 2015 Aug; 127(6):640-53. PubMed ID: 26036708
[TBL] [Abstract][Full Text] [Related]
6. Diabetic Macular Edema: Current Understanding, Molecular Mechanisms and Therapeutic Implications.
Zhang J; Zhang J; Zhang C; Zhang J; Gu L; Luo D; Qiu Q
Cells; 2022 Oct; 11(21):. PubMed ID: 36359761
[TBL] [Abstract][Full Text] [Related]
7. Vascular Endothelial Growth Factor and Diabetic Retinal Disease.
Ajlan RS; Silva PS; Sun JK
Semin Ophthalmol; 2016; 31(1-2):40-8. PubMed ID: 26959128
[TBL] [Abstract][Full Text] [Related]
8. [Pathophysiology and therapeutic progress of diabetic macular edema].
Li B; Ye JJ
Zhonghua Yan Ke Za Zhi; 2018 Aug; 54(8):625-630. PubMed ID: 30107656
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal Aflibercept Injection in Diabetic Macular Edema Patients with and without Prior Anti-Vascular Endothelial Growth Factor Treatment: Outcomes from the Phase 3 Program.
Do DV; Nguyen QD; Vitti R; Berliner AJ; Gibson A; Saroj N; Soo Y; Boyer DS
Ophthalmology; 2016 Apr; 123(4):850-7. PubMed ID: 26832658
[TBL] [Abstract][Full Text] [Related]
10. What have we learnt about the management of diabetic macular edema in the antivascular endothelial growth factor and corticosteroid era?
Agarwal A; Sarwar S; Sepah YJ; Nguyen QD
Curr Opin Ophthalmol; 2015 May; 26(3):177-83. PubMed ID: 25784111
[TBL] [Abstract][Full Text] [Related]
11. Evidence for anti-VEGF treatment of diabetic macular edema.
Bandello F; Berchicci L; La Spina C; Battaglia Parodi M; Iacono P
Ophthalmic Res; 2012; 48 Suppl 1():16-20. PubMed ID: 22907145
[TBL] [Abstract][Full Text] [Related]
12. Anti-VEGF therapy for diabetic macular edema.
Stewart MW
Curr Diab Rep; 2014 Aug; 14(8):510. PubMed ID: 24919750
[TBL] [Abstract][Full Text] [Related]
13. [Choice of treatment for diabetic macular edema].
Yang L; Zhang J
Zhonghua Yan Ke Za Zhi; 2017 Oct; 53(10):724-728. PubMed ID: 29050184
[TBL] [Abstract][Full Text] [Related]
14. Anti-VEGF Therapy for Diabetic Eye Diseases.
Bahrami B; Hong T; Gilles MC; Chang A
Asia Pac J Ophthalmol (Phila); 2017; 6(6):535-545. PubMed ID: 29076303
[TBL] [Abstract][Full Text] [Related]
15. Anti-angiogenesis drugs in diabetic retinopathy.
Jeganathan VS
Curr Pharm Biotechnol; 2011 Mar; 12(3):369-72. PubMed ID: 20939797
[TBL] [Abstract][Full Text] [Related]
16. The Role of Anti-VEGF Therapy in the Treatment of Diabetic Macular Edema.
Moshfeghi DM; Kaiser PK; Michels S; Midena E; Kitchens JW; Prenner JL; Regillo CD; Reichel E
Ophthalmic Surg Lasers Imaging Retina; 2016 Jun; 47(6 Suppl):S4-S14. PubMed ID: 27348433
[TBL] [Abstract][Full Text] [Related]
17. Functional and morphological changes in diabetic macular edema over the course of anti-vascular endothelial growth factor treatment.
Reznicek L; Cserhati S; Seidensticker F; Liegl R; Kampik A; Ulbig M; Neubauer AS; Kernt M
Acta Ophthalmol; 2013 Nov; 91(7):e529-36. PubMed ID: 23647578
[TBL] [Abstract][Full Text] [Related]
18. Anti-vascular endothelial growth factor drug treatment of diabetic macular edema: the evolution continues.
Stewart MW
Curr Diabetes Rev; 2012 Jul; 8(4):237-46. PubMed ID: 22515701
[TBL] [Abstract][Full Text] [Related]
19. INTRAVITREAL INJECTIONS OF ZIV-AFLIBERCEPT FOR DIABETIC MACULAR EDEMA: A Pilot Study.
Andrade GC; Dias JR; Maia A; Farah ME; Meyer CH; Rodrigues EB
Retina; 2016 Sep; 36(9):1640-5. PubMed ID: 26991646
[TBL] [Abstract][Full Text] [Related]
20. Aflibercept for the treatment of diabetic macular edema.
Harkins KA; Haschke M; Do DV
Immunotherapy; 2016 May; 8(5):503-10. PubMed ID: 26907516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
